Delta Biopharma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Delta Biopharma Private Limited Pharmaceutical Export Portfolio Dataset — 5 Products, $1.1M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Delta Biopharma Private Limited — Pharmaceutical Exporter Profile (2026) | 5 Products, $1.1M Trade | TransData Nexus

Delta Biopharma Private Limited

Indian Pharmaceutical Exporter · Antiviral & HIV Medications Specialist · $1.1M Total Trade · DGFT Verified

Delta Biopharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $1.1M across 5 products in 4 therapeutic categories. Based on 46 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Efavirenz ($300.0K), Sofosbuvir ($237.8K), Empagliflozin ($234.4K).

Delta Biopharma Private Limited — Export Portfolio & Destination Treemap

Delta Biopharma Private Limited pharmaceutical export portfolio — 5 products across 4 therapeutic categories. Source: Indian Customs (DGFT).

Who is Delta Biopharma Private Limited? — Company Overview & Market Position

Delta Biopharma Private Limited, incorporated on December 8, 2012, is a privately held pharmaceutical company based in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24100MH2012PTC238604. Its authorized share capital is ₹50.2 crore, with a paid-up capital of ₹50 crore. The registered office is located at 1017/1018 Corporate Avenue, Sonawala Road, Goregaon East, Mumbai, Maharashtra 400063.

Delta Biopharma specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company has established a significant presence in the global pharmaceutical market, exporting products to over 30 countries. Its product portfolio spans multiple therapeutic categories, with a notable focus on antiviral and HIV medications, antivirals, and diabetes and endocrine treatments.

What Does Delta Biopharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Efavirenz$300.0K 2

Product Portfolio — Top 5 by Export Value

Delta Biopharma Private Limited exports 5 pharmaceutical products across 4 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Efavirenz	Antivirals	$300.0K	6	0.5%	9
2	Sofosbuvir	Antiviral & HIV Medications	$237.8K	7	0.6%	7
3	Empagliflozin	Diabetes & Endocrine	$234.4K	15	3.5%	7
4	Emtricitabine	Antiviral & HIV Medications	$227.9K	7	0.2%	14
5	Linagliptin	Advanced Diabetes Medications	$80.5K	11	2.1%	5

Delta Biopharma Private Limited exports 5 pharmaceutical products across 4 therapeutic categories with a total export value of $1.1M. The top category is Antiviral & HIV Medications (43.1% of portfolio), followed by Antivirals (27.8%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Delta Biopharma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Delta Biopharma operates manufacturing facilities in Mumbai, Maharashtra, and Tirupati, Andhra Pradesh. The Mumbai facility serves as the company's headquarters and is equipped with state-of-the-art machinery and laboratories for research and development, quality assurance, and quality control. The Tirupati plant, located in Menakuru Village, Naidupeta Mandal, is situated within an industrial park, facilitating efficient production and distribution.

3Key Leadership

The leadership team at Delta Biopharma includes:

Rita Khanna: Director since December 8, 2012.
Chander Mohan Khanna: Director since December 8, 2012.
Rajat Chander Mohan Khanna: Director since December 8, 2012.
Rajiv Khanna: Director since March 31, 2015.
Jyoti Rani: Company Secretary since November 1, 2018.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Delta Biopharma Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Delta Biopharma has made significant strides in regulated markets, obtaining approvals from various health authorities. The company holds WHO-GMP certification, enabling it to export products to numerous countries. Additionally, Delta Biopharma has received FSSAI and Schedule M approvals, further solidifying its compliance with international standards.

2Emerging Markets

Delta Biopharma has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's WHO-GMP certification facilitates access to these regions, allowing it to meet the growing demand for quality pharmaceutical products. This strategic expansion underscores Delta Biopharma's commitment to global healthcare.

3Geographic Strategy

Delta Biopharma's geographic strategy involves a diversified approach, targeting both developed and emerging markets. The company's presence in over 30 countries mitigates concentration risk and demonstrates its adaptability to various regulatory environments. This strategic direction positions Delta Biopharma for sustained growth and market penetration.

Delta Biopharma Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

As of March 2026, specific details regarding Delta Biopharma's FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not publicly available. The company has not disclosed information about its interactions with the FDA, which may be due to the confidential nature of such regulatory processes.

2WHO & EU GMP

Delta Biopharma holds WHO-GMP certification, ensuring that its manufacturing processes meet international quality standards. This certification facilitates the company's ability to export products to various countries, including those in the European Union. However, specific details regarding EU GMP certificates and EDQM status are not publicly available.

3CDSCO & Indian Regulatory

Delta Biopharma has obtained manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), authorizing it to produce pharmaceutical products for both domestic and international markets. The company complies with Indian regulatory requirements, including approvals from state drug controllers and export No Objection Certificates (NOCs), ensuring adherence to national standards.

Delta Biopharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Delta Biopharma operates in a competitive landscape with several key players in the pharmaceutical industry. While specific market share data is not publicly disclosed, the company's focus on antiviral and HIV medications, antivirals, and diabetes and endocrine treatments positions it in direct competition with other pharmaceutical manufacturers specializing in these therapeutic areas. The company's adherence to international quality standards, such as WHO-GMP certification, provides a competitive edge in global markets.

2Key Differentiators

Delta Biopharma's key differentiators include its WHO-GMP certification, enabling exports to over 30 countries, and its comprehensive product portfolio covering primary care, cardiovascular, diabetology, pain management, nephrology, urology, immunology, and nephrology. The company's commitment to quality healthcare and adherence to international standards at every step of the manufacturing process further distinguish it in the pharmaceutical industry.

3Strategic Position

Delta Biopharma's current strategic direction focuses on manufacturing finished pharmaceutical formulations across various therapeutic areas, including antiviral and HIV medications, antivirals, and diabetes and endocrine treatments. The company's WHO-GMP certification and presence in over 30 countries underscore its commitment to global healthcare. Future outlooks suggest continued expansion into emerging markets and potential diversification into other therapeutic areas to meet global healthcare needs.

Buyer Due Diligence Brief — Evaluating Delta Biopharma Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Delta Biopharma has demonstrated a consistent track record in pharmaceutical manufacturing, with a total export value of $1.1 million USD across 46 shipments. The company's portfolio includes five products across four therapeutic categories, with a concentration of 100% in its top five products. This indicates a focused approach to product development and market penetration. The company's adherence to international quality standards, such as WHO-GMP certification, and its presence in over 30 countries reflect its reliability and commitment to quality.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

WHO-GMP Certification: Confirms adherence to international manufacturing standards.
EU GMP Certificate: Validates compliance with European Union manufacturing standards.
FDA Approval: Indicates compliance with U.S. Food and Drug Administration regulations.

Frequently Asked Questions — Delta Biopharma Private Limited

How many pharmaceutical products does Delta Biopharma Private Limited export from India?

Delta Biopharma Private Limited exports 5 pharmaceutical products across 4 therapeutic categories. The top exports are Efavirenz ($300.0K), Sofosbuvir ($237.8K), Empagliflozin ($234.4K), Emtricitabine ($227.9K), Linagliptin ($80.5K). Total export value is $1.1M.

What is Delta Biopharma Private Limited's total pharmaceutical export value?

Delta Biopharma Private Limited's total pharmaceutical export value is $1.1M, based on 46 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Delta Biopharma Private Limited cover?

Delta Biopharma Private Limited exports across 4 therapeutic categories. The largest are Antiviral & HIV Medications (43.1%, 2 products), Antivirals (27.8%, 1 products), Diabetes & Endocrine (21.7%, 1 products).

Get Full Delta Biopharma Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.